Discover 1,279 paid clinical trials in Chula Vista, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,279
EDX110 Randomized Control Trial for Treatment of DFUs
for
Wound Heal, Diabetic Foot Ulcer
Location: Vista CA, Santa Ana CA, Phoenix AZ, McAllen TX
Sponsor: ConvaTec Inc.
Sex: All
Age: 18 - 70+
Code: NCT07209358
Recruiting
Study of AMG0001 to Improve Ulcer Healing and Perfusion in Subjects With Peripheral Ischemic Ulcers
for
Peripheral Artery Disease,
Location: Carlsbad CA, Downey CA, Los Angeles CA,
Sponsor: AnGes USA, Inc.
Sex: All
Age: 18+
Code: NCT04267640
Phase2, Recruiting
Randomized Clinical Study Assessing NuShield Versus Standard of Care in Diabetic Foot Ulcers
for
Diabetic Foot Ulcer
Location: Carlsbad CA, Los Angeles CA, Fresno CA, Redwood City CA,
Sponsor: Organogenesis
Sex: All
Age: 18 - 70+
Code: NCT03855514
Recruiting
Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas
for
Brain and Central Nervous System Tumors
Location: Encinitas CA
Sponsor: San Diego Pacific Oncology & Hematology Associates
Sex: All
Age: 18+
Code: NCT00492687
Phase2, Recruiting
Clinical Study Of Affinity Versus SOC In The Management Of VLUs
for
Venous Leg Ulcer
Location: Carlsbad CA
Sponsor: Organogenesis
Sex: All
Age: 18 - 70+
Code: NCT04901013
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Tissue Repair Gel in Venous Leg Ulcers (US)
for
Venous Leg Ulcer, Venous Ulcer, Venous Stasis Ulcer,
Location: Vista CA, Los Angeles CA, Fresno CA, Castro Valley CA,
Sponsor: TR Therapeutics
Sex: All
Age: 18+
Code: NCT06707090
Phase3, Recruiting
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
for
Breast Neoplasms, Neoplasm Metastasis
Location: Oceanside CA, Irvine CA, Duarte CA, Chandler AZ,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07174336
Phase3, Recruiting
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod